Eosinophils in Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Immunology
• Neuroscience

Background:

• Eosinophils are increasingly recognized for their contribution to chronic intestinal inflammation in inflammatory bowel disease (IBD).
• Eosinophil accumulation in the gastrointestinal tract correlates with regulatory molecule variations, but their precise role in IBD-related gastrointestinal dysfunction remains unclear.

Purpose of the Study:

• To review the development, characterization, and recruitment mechanisms of gastrointestinal eosinophils.
• To analyze eosinophil-induced changes in the enteric nervous system (ENS) linked to IBD severity and dysfunction.
• To discuss potential molecular pathways for enteric neuronal injury and therapeutic interventions targeting eosinophils.

Main Methods:

• Literature review of clinical investigations and preclinical studies on eosinophils in IBD.
• Analysis of mechanisms of eosinophil recruitment and function in the gastrointestinal tract.
• Examination of the interplay between eosinophils, the ENS, and gastrointestinal dysfunction in IBD.

Main Results:

• Eosinophils are implicated in the pathogenesis of chronic intestinal inflammation and gastrointestinal dysfunction in IBD.
• Eosinophil infiltration and activation can lead to alterations in the ENS, potentially contributing to disease severity.
• Specific molecular pathways linking eosinophils to neuronal injury are being elucidated.

Conclusions:

• Eosinophils are significant contributors to IBD pathogenesis, impacting both inflammation and gastrointestinal function.
• Targeting eosinophils presents a promising therapeutic avenue for managing IBD and its associated gastrointestinal symptoms.
• Further research into eosinophil-ENS interactions is crucial for developing effective IBD treatments.